AntoineHageMD

Cardiology • Beverly Hills, CA

Cardiac Electrophysiology, Heart Failure & Transplantation

Physician

Join to view full profile

Dr. Hage is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hage's full profile

Already have an account?

Office
8536 Wilshire Blvd Fl 3
Beverly Hills, CA 90211
Phone+1 310-248-8300

Fax+1 310-248-8333

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1990 - 1991
Wright State UniversityResidency, Internal Medicine, 1988 - 1989
Wright State UniversityResidency, Internal Medicine, 1987 - 1987
Catholic University of LeuvenClass of 1980

Certifications & Licensure

CA State Medical License 1989 - 2025
OH State Medical License 1990 - 1994
IL State Medical License 1988 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Fellow (FACC) American College of Cardiology

Clinical Trials

Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
Completed
Phase 3
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Completed
Phase 3
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Completed
Phase 3
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

47 citations
Combination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trial
R. James White, Carlos Jerjes-Sánchez, Gisela Martina Bohns Meyer, Tomas Pulido, Pablo Sepúlveda
American Journal of Respiratory and Critical Care Medicine. 2020-03-15
134 citations
Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
Jon A. Kobashigawa, Jaime Moriguchi, Hillel Laks, Liane Wener, Antoine Hage
The Journal of Heart and Lung Transplantation. 2005-11-01
10 citations
The University of California at Los Angeles experience in heart transplantation.
Jon A. Kobashigawa, Hillel Laks, Davis C. Drinkwater, M. A. Hamilton, J. D. Moriguchi
Clinical Transplants. 1995-01-01

Press Mentions

Angioplasty May Be Feasible for Liver Transplantation Candidates with Heart DiseaseJune 22nd, 2011

Professional Memberships

American College of Cardiology - ACC
Member

Other Languages

Arabic, French